Stage (next event)
Phase 3 (Data)
Catalyst Info & Data Links
Title: AZD1222 (Vaccine) for COVID-19 - Phase 3 Data
Clinicaltrials.gov (NCT04516746): Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults
WHAT IS THE NEXT CATALYST EVENT?
Phase 3 Data
WHEN WILL THE EVENT (OR DID THE EVENT) OCCUR?
Mechanism of Action
MECHANISM OF ACTION / RATIONALE
AZD1222 (formerly ChAdOx1 nCoV-19), a recombinant adenovirus vaccine encoding the SARS-CoV-2 S protein
Description: Recombinant chimpanzee adenovirus vector expressing the SARS-CoV-2 S protein
source - Sheridan, C. (2020). Questions remain following first COVID-19 vaccine results. Nature Biotechnology.
Updated by HC
Prior Data (click to view full image)
Trial Design / Revenue (click to view full image)
See what the community is saying - click to see full post